Simon G E, VonKorff M, Rutter C, Wagner E
Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA.
BMJ. 2000 Feb 26;320(7234):550-4. doi: 10.1136/bmj.320.7234.550.
To test the effectiveness of two programmes to improve the treatment of acute depression in primary care.
Randomised trial.
Primary care clinics in Seattle.
613 patients starting antidepressant treatment.
Patients were randomly assigned to continued usual care or one of two interventions: feedback only and feedback plus care management. Feedback only comprised feedback and algorithm based recommendations to doctors on the basis of data from computerised records of pharmacy and visits. Feedback plus care management included systematic follow up by telephone, sophisticated treatment recommendations, and practice support by a care manager.
Blinded interviews by telephone 3 and 6 months after the initial prescription included a 20 item depression scale from the Hopkins symptom checklist and the structured clinical interview for the current DSM-IV depression module. Visits, antidepressant prescriptions, and overall use of health care were assessed from computerised records.
Compared with usual care, feedback only had no significant effect on treatment received or patient outcomes. Patients receiving feedback plus care management had a higher probability of both receiving at least moderate doses of antidepressants (odds ratio 1.99, 95% confidence interval 1.23 to 3.22) and a 50% improvement in depression scores on the symptom checklist (2.22, 1.31 to 3.75), lower mean depression scores on the symptom checklist at follow up, and a lower probability of major depression at follow up (0.46, 0.24 to 0.86). The incremental cost of feedback plus care management was about $80 ( pound50) per patient.
Monitoring and feedback to doctors yielded no significant benefits for patients in primary care starting antidepressant treatment. A programme of systematic follow up and care management by telephone, however, significantly improved outcomes at modest cost.
检验两项改善初级保健中急性抑郁症治疗效果的方案。
随机试验。
西雅图的初级保健诊所。
613名开始接受抗抑郁治疗的患者。
患者被随机分配至继续接受常规治疗或两种干预措施之一:仅反馈及反馈加护理管理。仅反馈包括基于药房和就诊的计算机化记录数据向医生提供反馈及基于算法的建议。反馈加护理管理包括通过电话进行系统随访、提供复杂的治疗建议以及由护理经理提供实践支持。
在首次开处方后3个月和6个月通过电话进行的盲法访谈包括来自霍普金斯症状清单的20项抑郁量表以及针对当前《精神疾病诊断与统计手册》第四版抑郁模块的结构化临床访谈。从计算机化记录中评估就诊情况、抗抑郁药处方以及医疗保健的总体使用情况。
与常规治疗相比,仅反馈对所接受的治疗或患者结局无显著影响。接受反馈加护理管理的患者接受至少中等剂量抗抑郁药治疗的可能性更高(优势比1.99,95%置信区间1.23至3.22),并且症状清单上的抑郁评分改善50%(2.22,1.31至3.75),随访时症状清单上的平均抑郁评分更低,随访时患重度抑郁症的可能性更低(0.46,0.24至0.86)。反馈加护理管理的增量成本约为每位患者80美元(50英镑)。
对开始接受抗抑郁治疗的初级保健患者而言,向医生进行监测和反馈未带来显著益处。然而,通过电话进行系统随访和护理管理的方案以适度成本显著改善了结局。